Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Hepato Cellular Carcinoma (HCC)
Fuzhou, Fujian
Hepato Cellular Carcinoma (HCC) Clinical Trials in Fuzhou, Fujian
1 recruiting
Fuzhou, Fujian, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence
Hepato Cellular Carcinoma (HCC)
Fudan University
165 enrolled
3 locations
NCT06812039
Feedback